Mapping the time course and associated factors of placebo response to systemic immunomodulatory treatments for atopic dermatitis
- 24 September 2025
- journal article
- Published by Elsevier in Journal of the American Academy of Dermatology
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Efficacy and Safety of Lebrikizumab in Combination With Topical Corticosteroids in Adolescents and Adults With Moderate-to-Severe Atopic DermatitisJAMA Dermatology, 2023
- Atopic dermatitisThe Lancet, 2020
- Placebo responses in randomized controlled trials for systemic therapy in atopic dermatitis: A systematic review and meta-analysisJournal of the American Academy of Dermatology, 2020
- Patient burden and quality of life in atopic dermatitis in US adultsAnnals of Allergy, Asthma & Immunology, 2018
- Atopic dermatitisNature Reviews Disease Primers, 2018